Immune thrombocytopenic purpura--from agony to ... [N Engl J Med. 2007] - PubMed

loading

Eltrombopag in thrombocytopenia. [N Engl J Med. 2008]
Eltrombopag in thrombocytopenia.
Lawson A. N Engl J Med. 2008 Mar 6; 358(10):1072; author reply 1072-3.
Review Eltrombopag--an oral thrombopoietin agonist. [Eur Rev Med Pharmacol Sci. 2012]
Review Eltrombopag--an oral thrombopoietin agonist.
Sharma V, Randhawa H, Sharma A, Aggarwal S. Eur Rev Med Pharmacol Sci. 2012 Jun; 16(6):743-6.
Review [Development of thrombopoietin receptor agonists]. [Rinsho Ketsueki. 2009]
Review [Development of thrombopoietin receptor agonists].
Miyakawa Y. Rinsho Ketsueki. 2009 Oct; 50(10):1434-43.
Eltrombopag in thrombocytopenia. [N Engl J Med. 2008]
Eltrombopag in thrombocytopenia.
Zimmer J, Hentges F, Andrès E. N Engl J Med. 2008 Mar 6; 358(10):1072; author reply 1072-3.
[Thrombopoietin-receptor agonists: a revolution in the therapeutic strategies of immune thrombocytopenic purpura?]. [Rev Med Interne. 2009]
[Thrombopoietin-receptor agonists: a revolution in the therapeutic strategies of immune thrombocytopenic purpura?].
Godeau B, Centre de référence labellisé pour la prise en charge des cytopénies auto-immunes de l'adulte. Rev Med Interne. 2009 Mar; 30(3):203-5. Epub 2008 Nov 18.

Passive transfer of collagen XVII-specific antibodies induces sustained blistering disease in adult mice. [Orphanet J Rare Dis. 2013]
Passive transfer of collagen XVII-specific antibodies induces sustained blistering disease in adult mice.
Chiriac MT, Licarete E, Sas AG, Rados AM, Lupan I, Chiriac AM, Speth H, Pop-Vancia V, Domsa I, Sesarman A, et al. Orphanet J Rare Dis. 2013 Jan 29; 8:17. Epub 2013 Jan 29.
Identification and characterization of anti-platelet antibodies in idiopathic thrombocytopenic purpura patients. [Iran J Public Health. 2012]
Identification and characterization of anti-platelet antibodies in idiopathic thrombocytopenic purpura patients.
Aghabeigi N, Lindsey N, Zamani A, Shishaeyan B. Iran J Public Health. 2012; 41(2):53-62. Epub 2012 Feb 29.
Review Pathophysiology and therapeutic options in primary immune thrombocytopenia. [Blood Transfus. 2011]
Review Pathophysiology and therapeutic options in primary immune thrombocytopenia.
Stasi R. Blood Transfus. 2011 Jul; 9(3):262-73. Epub 2010 Nov 26.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Immune thrombocytopenic purpura--from agony to agonist.
Immune thrombocytopenic purpura--from agony to agonist.
N Engl J Med. 2007 Nov 29 ;357(22):2299-301.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed